Health & Environmental Research Online (HERO)


Print Feedback Export to File
833407 
Journal Article 
Two-center Canadian report on the safety and effectiveness of Evolence Breeze 
Carruthers, J; Carruthers, A 
2009 
Yes 
Journal of Drugs in Dermatology
ISSN: 1545-9616 
8 
9 
830-834 
English 
19746675 
WOS:000275744400005 
Evolence Breeze, a new less viscous form of the ribose crosslinked Israeli porcine collagen Evolence, was approved for use in Canada as a cosmetic soft tissue augmenting agent on July 14, 2006. The purpose of this report is to review a one-year, 312 subject, pan facial injection site experience. This represents our initial experience with both subject satisfaction and product safety during this one year period approximately 1.5 years after Health Canada product approval.